[Response to interferon therapy using mutations in the HCV-NS5A]

Nihon Rinsho. 2011 May:69 Suppl 4:234-8.
[Article in Japanese]
No abstract available

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Mutation
  • Polyethylene Glycols / administration & dosage*
  • Recombinant Proteins / administration & dosage
  • Ribavirin / administration & dosage*
  • Viral Nonstructural Proteins / genetics*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Viral Nonstructural Proteins
  • Polyethylene Glycols
  • Ribavirin
  • NS-5 protein, hepatitis C virus
  • peginterferon alfa-2b